German-US molecular diagnostics company Epigenomics AG has appointed Gregory Hamilton as its new CEO. Hamilton succeeds Thomas Taapken, who served as both CEO and chief financial officer since 2012. The company said it expects to fill the CFO position shortly.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?